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Abstract
We studied the effect of endogenous prostaglandin E2 (PGE2) on interleukin 1 (IL-1) produc-
tion by peripheral blood monocytes from patients with rheumatoid arthritis (RA). IL-1 production
by RA monocytes was not different from that of monocytes from normal controls, when the cells
were either unstimulated or stimulated with lipopolysaccharide (LPS, 20 micrograms/ml), as mea-
sured by two different bioassays (thymocyte or fibroblast proliferation assay) and enzyme-linked
immunosorbent assay. However, IL-1 production by LPS-stimulated monocytes from RA patients
cultured in medium containing indomethacin, an inhibitor of PGE2 synthesis, was significantly
greater than that of monocytes from normal controls. In addition, the levels of PGE2 in culture
supernatants of unstimulated or LPS-stimulated monocytes from RA patients were higher than in
culture supernatants of monocytes from normal controls. Moreover, the increase of in vitro IL-2
production by RA T cells stimulated by phytohemagglutinin (PHA) was observed when mono-
cytes were removed from peripheral blood mononuclear cells. These results indicated that periph-
eral blood monocytes from RA patients could produce IL-1 in excess in vitro, but that in vivo IL-1
production by RA monocytes and IL-2 induction by RA T cells might be negatively regulated by
endogenous PGE2.
KEYWORDS: rheumatoid arthritis, monocytes, interleulin 1, prostaglandin E2, interleukin 2
∗PMID: 2330842 [PubMed - indexed for MEDLINE]
Copyright (C) OKAYAMA UNIVERSITY MEDICAL SCHOOL
1Yamamura et al.: Role of endogenous prostaglandin E2 in interleukin 1
Produced by The Berkeley Electronic Press, 1990
2Acta Medica Okayama, Vol. 44 [1990], Iss. 1, Art. 1
http://escholarship.lib.okayama-u.ac.jp/amo/vol44/iss1/1
3Yamamura et al.: Role of endogenous prostaglandin E2 in interleukin 1
Produced by The Berkeley Electronic Press, 1990
4Acta Medica Okayama, Vol. 44 [1990], Iss. 1, Art. 1
http://escholarship.lib.okayama-u.ac.jp/amo/vol44/iss1/1
5Yamamura et al.: Role of endogenous prostaglandin E2 in interleukin 1
Produced by The Berkeley Electronic Press, 1990
6Acta Medica Okayama, Vol. 44 [1990], Iss. 1, Art. 1
http://escholarship.lib.okayama-u.ac.jp/amo/vol44/iss1/1
7Yamamura et al.: Role of endogenous prostaglandin E2 in interleukin 1
Produced by The Berkeley Electronic Press, 1990
8Acta Medica Okayama, Vol. 44 [1990], Iss. 1, Art. 1
http://escholarship.lib.okayama-u.ac.jp/amo/vol44/iss1/1
